Healthcare Pharmaceutical Biotech

DataMEDS, AI. Acquires Helomics AI Cancer Diagnostics Lab and Precision Oncology CRO Businesses from Axe Compute

September 15, 2026 4:05 PM

DataMEDS AI, Inc. (NASDAQ:MEDS) ("DataMEDS"), a Health IT company vertically integrating health data acquisition and transfer, today announced that it completed the acquisition of artificial intelligence cancer diagnostics laboratory business Helomics Corporation ("Helomics") from Axe Compute Inc. (NASDAQ:AGPU) ("Axe Compute" or the "Company"), a neocloud AI infrastructure platform. Under the agreement, DataMEDS acquired Axe Compute's...

Read more

Who is the Best Plastic Surgeon in Seattle?

September 15, 2026 12:00 PM

Dr. Javad Sajan of Allure Esthetic has been recognized by Seattle Mag and Seattle Met as Seattle's best plastic surgeon. As a certified surgeon, Dr. Sajan has performed thousands of procedures across facial, breast, body, and gender-affirming surgery. His experience is further reflected in more than 1,000 Google reviews from patients. These credentials, patient feedback, and local media recognition support Dr. Sajan's standing as the best...

Read more

Sugar Clinics: A One-Stop Shop for Improved Diabetes Care in Mexico

September 15, 2026 10:35 AM

For many, the journey to manage diabetes is as challenging as the diagnosis itself. Fragmented public healthcare pathways often force patients to spend months navigating care. They move from one facility to another before receiving the full treatment they need-if they can afford it at all. These systemic challenges result in long delays, rising personal costs, and growing treatment fatigue-turning accessing care and adherence to treatment into a...

Read more

Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June

September 15, 2026 10:30 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its wholly owned subsidiary, Cana Laboratories S.A. ("Cana"), has secured new five-year contract manufacturing agreements with Target Pharma totaling approximately 5.2 million units. ORDERBOOK 32.7M+ units GROWTH SINCE JUNE +31% in under three months ADDED IN SEPTEMBER 7.7M units, two agreements...

Read more

Renew Health + Recovery Purchases Assets of Aware Recovery Care

September 15, 2026 10:25 AM

Renew Health + Recovery today announced the completion of a transaction under which it purchased many of the assets of the in-home substance use disorder treatment provider, Aware Recovery Care. Renew will serve without interruption clients and families as it has acquired many of the clinical models and care teams. "Our clients and the communities we serve can expect exactly what they always have - dedicated care teams delivering high-quality...

Read more

Sacred Connection Partners with Non-Profit Conexão Ancestral to Fight Botanical Exploitation and Fund Vital Amazonian Indigenous Projects

September 15, 2026 10:00 AM

In response to the rapid rise of counterfeiting, synthetic adulteration, and cultural exploitation in the global plant medicine market, Sacred Connection has expanded its direct-trade framework through a formal partnership with its non-profit arm, Conexão Ancestral, ensuring that commercial success translates directly into community-led Amazonian development. As global demand for sacred Amazonian botanicals accelerates, commercial middlemen...

Read more

UTMD Announces Self-Tender for 20% of Its Shares

September 15, 2026 10:00 AM

Utah Medical Products, Inc. (Nasdaq:UTMD) announces today that it intends to repurchase at a price of $75.00 per share up to 650,000 of its shares, if tendered and not withdrawn by stockholders on or before October 7, representing approximately 20% of its currently outstanding shares. The offering price is 17% higher than the average daily closing price of UTMD shares trading in the open market during the last twelve months, and 21% higher than...

Read more

Emergency Care Partners Expands National Footprint to Providing Support to 12 Physician Practice Groups Across 10 States, Reinforcing Commitment to Local Clinical Autonomy

September 15, 2026 9:55 AM

Emergency Care Partners (ECP), a leading emergency medicine organization, announced that it now provides management services to 12 independent physician groups across 10 states. This milestone reflects ECP's steady, disciplined expansion strategy centered on empowering independent emergency medicine practices with operational resources while preserving local physician autonomy. In a healthcare environment increasingly shaped by operational...

Read more

Revive Therapeutics to Expand Bucillamine IP and Orphan Drug Portfolio Across Medical Countermeasures and Rare Diseases

September 15, 2026 9:35 AM

Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB:RVVTF)(CSE:RVV)(Frankfurt:31R), a life sciences company focused on the research and development of therapeutics for biodefence and pandemic preparedness, today outlined its strategy to strengthen and expand the intellectual property and regulatory portfolio supporting bucillamine across medical countermeasures ("MCMs") and rare diseases. Revive's objective is to build bucillamine into a...

Read more

Clinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in 
DR Congo with 48% Crude Fatality Rate, Says NanoViricides

September 15, 2026 9:25 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that its Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for the Current Bundibugyo Ebolavirus and other Ebola viruses in the Democratic Republic of Congo ("DRC") is scheduled to start next week at an Ebola Treatment Center in the Ituri province. "NV-387 being an oral drug with...

Read more

Ensysce Biosciences Advances CRPS Program at Painweek 2026, Contributes to FDA Hearing on Psychedelic Drug Regulation

September 15, 2026 9:15 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company") a clinical-stage biotechnology company developing novel neuroplastogenic therapies beyond mood disorders, with an initial focus on CRPS (Complex Regional Pain Syndrome), hosted a symposium at PainWeek 2026. The Symposium was attended by more than 320 pain management professionals. Dr. Jeff Gudin provided background on the Ensysce novel program to provide safer opioids for...

Read more

Who Does the Best Facelift in Oklahoma?

September 15, 2026 9:00 AM

Patients comparing facelift surgeons in Oklahoma look beyond surface-level results, they want to know how a surgeon approaches facial aging at a structural level. They want to know how a surgeon trained, how many facelift procedures they have actually performed, and whether the surgical plan will be built around their face. At Cosmetic Surgery Affiliates in Oklahoma City, Dr. Erik Nuveen is regarded by patients as the best facelift surgeon in...

Read more

Thank You! CVS Health Awards Grant to Windy City Harvest During Grace Manor Community Event in Chicago, Illinois

September 15, 2026 9:00 AM

Last month, CVS Health, Aetna Better Health of Illinois, Oak Street Health and community leaders gathered at Grace Manor in Chicago's North Lawndale neighborhood to host a resident-focused resource fair designed to support health, wellness, education and economic opportunity. The event brought together residents, local leaders and community organizations for a day of health services, resource connections and family-friendly activities. Elected...

Read more

Jaguar Health, Inc. Announces Reverse Stock Split

September 15, 2026 9:00 AM

Jaguar Health, Inc. (Nasdaq:JAGX) ("Jaguar" or the "Company") today announced that the Company will effect a reverse stock split of its issued and outstanding voting common stock ("Common Stock"), at an exchange ratio of 1-for-15, on Thursday, September 17, 2026 (the "Effective Date") in order to support the Company's compliance with Nasdaq's listing standards. The Company's Common Stock will begin trading on a split-adjusted basis when the...

Read more

Medical Care Technologies Inc. (OTCID:MDCE) Details StrainScan Pro's On-Device Visual Inspection Pipeline for iPad Air

September 15, 2026 8:57 AM

Medical Care Technologies Inc. (OTCID:MDCE) today outlined the on-device visual inspection pipeline now being applied inside StrainScan Pro on iPad Air. The process is designed as a four-stage analytical workflow: image acquisition, contextual indexing, differential visual analysis, and exception routing. The platform is live at https://strainscanpro.com. This update follows MDCE's recent StrainScan Pro work - agricultural demonstration...

Read more

Healthcare CIOs are Shifting from Data Retention to Data Lifecycle Management

September 15, 2026 8:00 AM

MediQuant, a leader in healthcare data archiving and lifecycle management, today shared new market insights into how health system technology leaders are rethinking long-term data strategy. As health systems modernize core applications, expand cloud environments and prepare data for AI-enabled use cases, healthcare technology executives say the conversation about legacy and enterprise data is changing. Rather than focusing primarily on how long...

Read more

Study Finds Healthcare Concern Jumps From 31% to 74% After Federal Debt Connection Is Explained

September 15, 2026 7:50 AM

Black Book Research today announced the publication of "The $40 Trillion Healthcare Question: National Healthcare Consumer Awareness, Expectations & Household Resilience Study," examining how Americans understand and believe they would experience the healthcare consequences of sustained federal fiscal pressure. The Q3 2026 study reports online and panel findings from 1,500 U.S. adults age 18 and older in Q3. The study identifies a substantial...

Read more

Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2026

September 14, 2026 5:20 PM

Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm today announced that revenues for the three and nine months ended July 31, 2026 were approximately $2.3 million and $7.3 million, respectively, representing increases of approximately $0.4 million and $0.5 million compared to the same periods last year. For the three and nine months ended July...

Read more

Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market

September 14, 2026 3:59 PM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has engaged Prime Ledger Inc. ("Prime Ledger"), a digital asset advisory and tokenization firm, to structure a tokenized financing backed by the Company's intellectual property in CCX0722, an ingestible hydrogel-based medical device in development for weight management. Prime Ledger will serve...

Read more

Amid Growing Physician Shortages, Desert Oasis Healthcare Expands Access to Local Care

September 14, 2026 12:50 PM

For more than four decades, Desert Oasis Healthcare (DOHC) has been committed to providing high-quality, coordinated healthcare close to home for people throughout the Coachella Valley and surrounding communities. Today, more than 60,000 members and patients rely on DOHC for care, with access to a broad network of primary care physicians, specialists and healthcare services across the region. The need for local access to physicians is especially...

Read more